ArticlebioRxiv : the preprint server for biology2025
Synergistic Arg-C Ultra and Lys-C Digestion for Quantitative Proteomics.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Shotgun proteomics hinges on complete enzymatic digestion of proteins into peptides. Incomplete digestion narrows proteome coverage and inflates variability in quantitative workflows, whether label-free DIA or multiplexing with isobaric tags. Sequential Lys-C/Trypsin digestions mitigate missed cleavages at lysine residues, but arginine sites remain a persistent challenge. Arg-C Ultra, a recently released cysteine protease, efficiently targets arginine residues but requires reducing conditions that inactivate Lys-C activity and compromise NHS-ester labeling in multiplexed workflows. Here, we systematically characterized Arg-C Ultra and Lys-C with chromogenic substrates that mimic arginine- and lysine-containing peptides, as well as shotgun proteomics. Arg-C Ultra operates optimally at room temperature, pH 7.5-8.5, under reducing conditions, whereas Lys-C is most active at 37 °C, pH 7.5-8.5, yet rapidly loses activity when exposed to common reductants. Among tested reducing agents, 1 mM TCEP uniquely preserved TMTpro integrity while sustaining Arg-C Ultra activity. Guided by these insights, we established a sequential digestion workflow that is fully compatible with both label-free DIA and TMTpro multiplexing. Proteins are first digested overnight with Lys-C at 37 °C (pH 8.5), then treated with 1 mM TCEP and Arg-C Ultra at room temperature (pH 8.5). The resulting peptides can be analyzed directly by label-free DIA or subjected to TMTpro labeling for multiplexed quantification. Applied to HeLa cell lysates, this protocol achieved >99% arginine and 95% lysine cleavage efficiencies, boosting the number of quantified proteins by 6% in label-free DIA and 11% in TMTproC experiments. Replicate measurements displayed reproducibility that approached the limits set by ion statistics. Thus, the introduced synergistic Lys-C/Arg-C Ultra digestion strategy enhances proteome coverage with excellent quantitative reproducibility across both label-free and multiplexed platforms.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.